<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Both <z:hpo ids='HP_0009800'>gestational diabetes</z:hpo> mellitus (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e>) and mild <z:hpo ids='HP_0000833'>glucose intolerance</z:hpo> in pregnancy identify women at increased risk of future type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>In this context, we queried whether metabolic changes that occur in the 1st year postpartum vary in relation to gestational <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance status </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS: Three-hundred-and-ninety-two women underwent <z:chebi fb="105" ids="17234">glucose</z:chebi> challenge test (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GCT</z:e>) and oral <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance test (OGTT) in pregnancy followed by repeat OGTT at both 3 months' postpartum and 12 months' postpartum </plain></SENT>
<SENT sid="3" pm="."><plain>The antepartum testing defined four gestational <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance groups: <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e> (n = 107); gestational <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> (GIGT) (n = 75); abnormal <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GCT</z:e> with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance (NGT) on OGTT (abnormal <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GCT</z:e> NGT) (n = 137); and <z:mpath ids='MPATH_458'>normal</z:mpath> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GCT</z:e> with NGT on OGTT (<z:mpath ids='MPATH_458'>normal</z:mpath> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GCT</z:e> NGT) (n = 73) </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The prevalence of dysglycemia progressively increased across the groups from <z:mpath ids='MPATH_458'>normal</z:mpath> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GCT</z:e> NGT to abnormal <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GCT</z:e> NGT to GIGT to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e> at both 3 months' postpartum (2.7% to 10.2% to 18.7% to 34.6%, P &lt; 0.0001) and 12 months' postpartum (2.7% to 11.7% to 17.3% to 32.7%, P &lt; 0.0001) </plain></SENT>
<SENT sid="5" pm="."><plain>Between 3 and 12 months' postpartum, the groups did not differ with respect to changes in waist circumference, weight, or insulin sensitivity </plain></SENT>
<SENT sid="6" pm="."><plain>Importantly, however, they exhibited markedly different changes in beta-cell function (Insulin Secretion-Sensitivity Index-2 [ISSI-2]) (P = 0.0036), with ISSI-2 declining in both the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e> and GIGT groups </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, on multiple linear regression analysis, both <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e> (t = -3.06, P = 0.0024) and GIGT (t = -2.18, P = 0.03) emerged as independent negative predictors of the change in ISSI-2 between 3 and 12 months' postpartum </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Women with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e> and GIGT exhibit declining beta-cell function in the 1st year postpartum that likely contributes to their future diabetic risk </plain></SENT>
</text></document>